Soft_tissue_sarcoma_of_the_pleural_cavity._Seventeen_cases_of_soft_tissue_sarcoma_(STS)_developing_in_the_pleural_cavity_were_collected_from_Japanese_hospitals,_and_their_clinical_and_pathologic_findings_summarized._Eight_of_the_17_patients_had_a_15-year_to_50-year_(mean,_28.8)_history_of_chronic_pleural_inflammatory_disease_(pleuritis,_pyothorax,_and_pulmonary_tuberculosis)_before_the_onset_of_the_pleural_sarcoma._Histologically,_malignant_fibrous_histiocytoma_was_the_most_common_tumor_type_(11_cases),_followed_by_angiosarcoma_(four)._The_age_at_diagnosis_of_the_sarcoma_ranged_from_15_to_74_years_(mean,_58);_the_male-to-female_ratio_was_3.3:1._In_the_eight_cases_of_sarcoma_associated_with_chronic_pleural_inflammatory_disease,_male_preponderance_was_more_marked_(7:1)._The_commonest_presenting_symptom_was_chest_pain._A_mass_could_be_detected_by_chest_roentgenograms_in_13_patients_and_computed_tomographic_scans_in_15_patients._No_patient_had_distant_metastases_at_first_admission._Thirteen_patients_were_treated_by_surgery,_chemotherapy,_and/or_radiation_therapy._Thirteen_of_the_17_patients_died_1_to_87_months_(mean,_14.2)_after_therapy_for_STS._The_actuarial_1-year_survival_rate_was_38.5%._These_findings_suggest_that_long-standing_pleural_inflammation_might_be_an_etiologic_factor_for_development_of_pleural_STS.